New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 5, 2012
16:43 EDTDCTHDelcath Systems secures $25M committed equity financing facility
Delcath Systems announced that it has obtained a committed equity financing facility under which it may sell up to $35M of its registered common stock to Terrapin Opportunity over a 24-month period. Delcath is not obligated to utilize any of the $35M facility and remains free to enter into and consummate other equity and debt financing transactions, subject to certain restrictions.
News For DCTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 29, 2015
09:04 EDTDCTHDelcath Systems announces results from CHEMOSAT Delivery System
Subscribe for More Information
May 27, 2015
08:05 EDTDCTHDelcath Systems's Chemosat shows positive results in Opinion Leader Forum
Subscribe for More Information
May 26, 2015
09:26 EDTDCTHDelcath Systems names Dr. Jennifer Simpson president and CEO
Subscribe for More Information
May 21, 2015
08:07 EDTDCTHDelcath Systems begins enrollment for Phase trial of Melphalan/IDS
Delcath Systems' intrahepatic cholangiocarcinoma study cohort of its expanded Global Phase 2 Clinical Trial Program of Melphalan/HDS for use in the treatment of patients with unresectable hepatocellular carcinoma - primary liver cancer, or HCC - has opened for patient enrollment. The ICC study will be conducted at the same hospitals in Europe participating in the company's Phase 2 HCC trial, and ICC enrollment is now open at Goethe University Hospital in Frankfurt, the Medical School Hannover and Jena University Hospital. Additional centers in Germany and the U.K. are expected to open for enrollment in the coming weeks.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use